The neurobiological mechanisms underlying extinction of fear memories have attracted considerable experimental interest in recent years, due in part to the clinical implications of this line of research for the treatment of fear-based psychiatric disorders (Milad et al. 2006;Sotres-Bayon et al. 2006). Several years ago, it was discovered that antagonists of the L-type voltage-gated calcium channel (L-VGCC) impair both extinction learning and longterm recall of fear extinction. In those studies, mice given systemic administration of either of the dihydropyridine (DHP) compounds nifedipine or nimodipine were observed to exhibit impairments in fear extinction, as measured by "freezing" behavior, both within a session and also when tested ∼24 h later (Cain et al. 2002(Cain et al. , 2005Suzuki et al. 2004). This finding was of interest given the well-established role of L-VGCCs in synaptic plasticity (Grover and Teyler 1990), in which signaling via the L-VGCC is thought to link activity at the membrane with transcriptional events in the nucleus (Dolmetsch et al. 2001). Further, L-VGCCs are known to play an essential role in synaptic plasticity in the amygdala (Weisskopf et al. 1999;Bauer et al. 2002), suggesting that signaling via L-VGCCs might be a mechanism by which long-term extinction memories are formed and stored. While an initially attractive hypothesis, three new articles appearing in this issue of Learning & Memory force us to re-examine that view. (Moosmang et al. 2005). Surprisingly, however, McKinney et al. (2008) find that mice lacking Ca v 1.2 in the forebrain have intact acquisition, consolidation, and extinction of fear memory. Thus, using a genetic approach, forebrainexpressed Ca v 1.3 appears necessary for fear memory consolidation, but neither Ca v 1.3 nor Ca v 1.2 appears to be necessary, at least in isolation, for fear memory extinction.Turning to a pharmacological analysis, McKinney et al. (2008) next revisit the question of whether L-VGCC antagonists impair fear extinction, and, if so, why this method of manipulating L-VGCCs is so much more effective than using a molecular genetic approach. They first verify that systemic administration of a dose of nifedipine that has been used in previous experiments (Cain et al. 2002(Cain et al. , 2005 impairs fear extinction. In their hands, mice treated with nifedipine exhibit impaired withinsession extinction relative to vehicle-injected mice and impaired extinction recall ∼24 h later. Remarkably, however, this same dose of nifedipine is observed to impair locomotor activity in an open field test and to exhibit aversive properties in its own right. That is, pairing of nifedipine alone with a novel context appears sufficient to condition a long-lasting fear-like response to that context and in a context-specific manner. Effectively, extinction training under the influence of nifedipine appears to amount to retraining using a different US. Thus, the authors suggest, the within-session impairment of fear extinction following systemic injections of L-VGCC an...